These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 7745818

  • 1. [Antibacterial activities of fosfomycin against recent clinical isolates from patients of otitis media and otitis externa].
    Deguchi K, Yokota N, Koguchi M, Suzuki Y, Fukayama S, Ishihara R, Oda S.
    Jpn J Antibiot; 1995 Feb; 48(2):293-8. PubMed ID: 7745818
    [Abstract] [Full Text] [Related]

  • 2. [Antibacterial activities of cefmenoxime against recent clinical isolates from patients of otitis media and otitis externa].
    Deguchi K, Yokota N, Koguchi M, Suzuki Y, Fukayama S, Ishihara R, Oda S.
    Jpn J Antibiot; 1993 Oct; 46(10):850-9. PubMed ID: 8254887
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Studies on the combined effect of fosfomycin with sulbactam/cefoperazone on methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa].
    Niida M, Yoshida T, Kohmoto A, Ogawa M, Hashimoto H, Deguchi K.
    Jpn J Antibiot; 1994 Jan; 47(1):1-10. PubMed ID: 8114267
    [Abstract] [Full Text] [Related]

  • 6. [Antibacterial activities and electron microscopic studies of imipenem in combination with fosfomycin against methicillin and fosfomycin resistant strains of Staphylococcus aureus].
    Saionji K, Shitara S, Kobayashi I.
    Jpn J Antibiot; 1990 Mar; 43(3):379-87. PubMed ID: 2374289
    [Abstract] [Full Text] [Related]

  • 7. [Combination effect of fosfomycin otic solution and norfloxacin against chronic otitis media].
    Uno Y.
    Kansenshogaku Zasshi; 1999 Apr; 73(4):291-7. PubMed ID: 10356885
    [Abstract] [Full Text] [Related]

  • 8. [Activities of antibiotics against methicillin-resistant Staphylococcus aureus with particular reference to synergetic effect between ticarcillin and fosfomycin on penicillinase non-producing methicillin-resistant S. aureus].
    Morikawa Y, Yoshioka Y, Toshima M.
    Jpn J Antibiot; 1993 Jun; 46(6):421-7. PubMed ID: 8360977
    [Abstract] [Full Text] [Related]

  • 9. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. I. The combined effect of arbekacin with fosfomycin or clavulanic acid/ticarcillin].
    Deguchi K, Yokota N, Koguchi M, Nakane Y, Suzuki Y, Fukayama S, Ishihara R, Oda S.
    Jpn J Antibiot; 1992 Aug; 45(8):949-57. PubMed ID: 1433901
    [Abstract] [Full Text] [Related]

  • 10. [In vitro effects of combinations of antibiotics against highly-fosfomycin-resistant, methicillin-resistant Staphylococcus aureus. With special reference to efficacies of combinations of imipenem/cilastatin and cephems].
    Kouda M.
    Jpn J Antibiot; 1993 Feb; 46(2):142-53. PubMed ID: 8331774
    [Abstract] [Full Text] [Related]

  • 11. Combination chemotherapy for infections due to methicillin-resistant Staphylococcus aureus with combination therapy by cefuzonam and fosfomycin or minocycline in the urologic field.
    Matsumoto T, Kubo S, Haraoka M, Takahashi K, Tanaka M, Sakumoto M, Kumazawa J.
    Clin Ther; 1993 Feb; 15(5):819-28. PubMed ID: 8269448
    [Abstract] [Full Text] [Related]

  • 12. [Bacteriologic evaluation of otitis externa and chronic otitis media].
    Kuczkowski J, Samet A, Brzoznowski W.
    Otolaryngol Pol; 2000 Feb; 54(5):551-6. PubMed ID: 11202342
    [Abstract] [Full Text] [Related]

  • 13. [Combination effects of fosfomycin and other oral antimicrobial agents against methicillin-resistant Staphylococcus aureus].
    Akiyama H, Yamada T, Shimoe K, Torigoe R, Kanzaki H, Arata J.
    Nihon Hifuka Gakkai Zasshi; 1990 Nov; 100(12):1257-61. PubMed ID: 2077154
    [Abstract] [Full Text] [Related]

  • 14. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Shimizu Y, Terai T, Inoue H, Nakadate T, Ito C, Yoshida T, Ohno I, Tanno Y, Arakawa M, Igarashi K, Okada M, Ozaki K, Aoki N, Kitamura N, Sekine O, Suzuki Y, Nakata K, Nakatani T, Inagawa H, Kusano N.
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [Abstract] [Full Text] [Related]

  • 15. [In vitro studies on the combined effects of arbekacin and fosfomycin on methicillin-resistant Staphylococcus aureus].
    Watanabe T, Kanno M, Sobu K, Takase Y, Yoshida T.
    Jpn J Antibiot; 1995 Feb; 48(2):284-92. PubMed ID: 7745817
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Study of clinical bacteriological efficacy in a cefmenoxime ototopical solution].
    Deguchi K, Fukayama S, Nishimura Y, Nishike A, Oda S, Sato S, Matsumoto Y, Ikegami R, Yokota N, Tanaka S.
    Jpn J Antibiot; 1985 Jul; 38(7):1739-49. PubMed ID: 3906166
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Bacteriological studies on fosfomycin. Antibacterial activity in vitro and in vivo (author's transl)].
    Miyauchi K, Yoshida T, Kasai T, Saito T, Hirano H.
    Jpn J Antibiot; 1975 Jun; 28(3):320-30. PubMed ID: 807758
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.